NCT00334126View on ClinicalTrials.gov

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

399

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

September 30, 2007

Conditions

Schizophrenia

Interventions

DRUG

paliperidone ER tablets, quetiapine tablets, placebo - all over encapsulated

All Listed Sponsors

collaborator

Janssen, LP

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00334126 - Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter